Empowered Funds’s Prelude Therapeutics PRLD Stock Holding History
Bought
Maintained
Sold
Other funds holding PRLD
Empowered Funds's PRLD Position: Q3 2026 in Review
Empowered Funds opened a new position in Prelude Therapeutics (PRLD) in Q3 2026: 59,978 shares worth $235K. The stake represents ﹤0.01% of the portfolio and ranks #2163 among its holdings.
59 funds tracked by Wall St. Rank hold PRLD as of Q3 2026.
- Empowered Funds held 59,978 shares of Prelude Therapeutics worth $235K as of Q3 2026.
- Prelude Therapeutics was a new Empowered Funds position in Q3 2026.
- Prelude Therapeutics made up ﹤0.01% of Empowered Funds's portfolio in Q3 2026, its #2163 holding.
- 59 funds tracked by Wall St. Rank held Prelude Therapeutics as of Q3 2026.
Based on Empowered Funds's 13F filing for Q3 2026, filed 13 Nov 2026.